Entrepreneur
Pioneera Biosciences
Pioneera Biosciences develops next-generation immunotherapies, including CAR-X "living drugs," using an AI-driven design platform called Discovery 4.0™. This technology engineers superior Chimeric Antigen Receptors (CARs) and other constructs to prevent antigen escape in cell and gene therapies. The company focuses on creating safer, more effective treatments for oncology and autoimmune diseases through intelligent construct discovery.
Updated 29 days ago
Funding
Raised to date
$5.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 2 rounds
P- Seed
- Seed
Incomplete round history. $5.3M of the $5.3M reported total isn’t matched to a known round (2 known rounds have undisclosed amounts).
RoundDateAmountValuationInvestors
Founders
Product
Features
- Pioneera Biosciences develops next-generation immunotherapies, including CAR-X "living drugs," using an AI-driven design platform called Discovery 4.0™. This technology engineers superior Chimeric Antigen Receptors (CARs) and other constructs to prevent antigen escape in cell and gene therapies. The company focuses on creating safer, more effective treatments for oncology and autoimmune diseases through intelligent construct discovery.